Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.

Spiro SG, Rudd RM, Souhami RL, Brown J, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V, Parmar MK, Peake MD, Stephens RJ, Thorpe H, Waller DA, West P; Big Lung Trial participants.

Thorax. 2004 Oct;59(10):828-36.

2.

Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.

Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG.

Eur J Cardiothorac Surg. 2004 Jul;26(1):173-82.

PMID:
15200998
3.

Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.

Maslove L, Gower N, Spiro S, Rudd R, Stephens R, West P.

Thorax. 2005 Jul;60(7):564-9.

4.

Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.

Cartei G, Cartei F, Cantone A, Causarano D, Genco G, Tobaldin A, Interlandi G, Giraldi T.

J Natl Cancer Inst. 1993 May 19;85(10):794-800.

PMID:
8387607
5.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, Villa E, Verusio C, Cetto GL, Santo A, De Pangher V, Artioli F, Cacciani GC, Parodi G, Soresi F, Ghi MG, Morabito A, Biason R, Giusto M, Mosconi P, Chiarion Sileni V; GSTVP (Gruppo di Studio Tumori Polmonari del Veneto).

Lung Cancer. 2004 Jan;43(1):83-91.

PMID:
14698542
7.

Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.

Berthelot JM, Will BP, Evans WK, Coyle D, Earle CC, Bordeleau L.

J Natl Cancer Inst. 2000 Aug 16;92(16):1321-9.

PMID:
10944554
8.

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, Lopez P, Anderson H, Gustafson N, Jeynes A, Gallant G, Washington T, Thatcher N.

J Natl Cancer Inst. 2000 Jul 5;92(13):1074-80.

PMID:
10880550
9.

Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.

van den Hout WB, Kramer GW, Noordijk EM, Leer JW.

J Natl Cancer Inst. 2006 Dec 20;98(24):1786-94.

PMID:
17179480
11.
12.

Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain.

Anelli A, Lima CA, Younes RN, Gross JL, Fogarolli R.

Rev Hosp Clin Fac Med Sao Paulo. 2001 Mar-Apr;56(2):53-8.

13.

A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.

Jiang J, Liang X, Zhou X, Huang R, Chu Z.

Lung Cancer. 2007 Sep;57(3):348-58. Epub 2007 May 7.

PMID:
17485133
14.

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.

Cancer Prev Control. 1997 Aug;1(3):249-59.

PMID:
9765750
16.

Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.

Brown J, Thorpe H, Napp V, Fairlamb DJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG, Stephens RJ, Waller D, West P, Peake MD.

J Clin Oncol. 2005 Oct 20;23(30):7417-27. Epub 2005 Sep 12.

PMID:
16157935
17.

Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?

Numico G, Russi E, Merlano M.

Lung Cancer. 2001 Jun;32(3):213-26. Review.

PMID:
11390003
18.

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.

Billingham LJ, Bathers S, Burton A, Bryan S, Cullen MH.

Lung Cancer. 2002 Aug;37(2):219-25.

PMID:
12140146
19.

Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.

Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.

J Clin Oncol. 2008 Apr 10;26(11):1886-92. doi: 10.1200/JCO.2007.12.2614.

PMID:
18398154
20.

A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial.

Fairlamb D, Milroy R, Gower N, Parmar M, Peake M, Rudd R, Souhami R, Spiro S, Stephens R, Waller D.

Radiother Oncol. 2005 May;75(2):134-140.

PMID:
16094738

Supplemental Content

Support Center